Mesenchymal Stromal Cells Do Not Increase the Risk of Viral Reactivation Nor the Severity of Viral Events in Recipients of Allogeneic Stem Cell Transplantation

Mesenchymal stromal cells (MSC) are tested in clinical trials to treat graft versus host disease (GvHD) after stem cell transplantation (SCT). In vitro studies demonstrated MSC's broad immunosuppressive activity. As infections represent a major risk after SCT, it is important to understand the...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lucchini, Giovanna, Dander, Erica, Pavan, Fabio, Di Ceglie, Irene, Balduzzi, Adriana, Perseghin, Paolo, Gaipa, Giuseppe, Algarotti, Alessandra, Introna, Martino, Rambaldi, Alessandro, Rovelli, Attilio, Biondi, Andrea, Biagi, Ettore, D'Amico, Giovanna
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2012
Sujets:
Clinical Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3369546/
https://ncbi.nlm.nih.gov/pubmed/22701127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/690236
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires